A report from the Court of Auditors commissioned by the Senate Social Affairs Committee points to the acts of medical biology considered too expensive for the Health Insurance, summoned to save money.
This excessive expenditure on medical biology can be explained by the increase in the number of procedures. The number ofmedical acts should therefore be reduced, particularly in hospitals. “A 10% to 15% reduction in the number of procedures (at the hospital) would allow savings of 200 to 300 million euros”, estimates Rue Cambon.
Among the avenues recommended for controlling spending, rue Cambon recommends a 7.5% reduction in the prices of medical analyzes. Since 2006, the pricing of biology acts has been regularly revised downwards, to the chagrin of biologists.
The Union of Biologists therefore takes a very negative view of this incentive to lower prices. In a press release published on their site, he judges that this request for additional effort is “irresponsible in terms of public health but also of the economic balance of medical biology laboratories”. “To play too much with medical biology, it is the performance and the quality of the offer of city care which will be degraded”, protested François Blanchecotte, president of the union.
